Profile
VNRX DHR-PB TMO DHR IQV A
Company Name VolitionRx Limited Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IQVIA Holdings Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $62.94M $916.76B $231.76B $197.82B $43.69B $40.06B
Employees 0.11K 79.00K 122.00K 61.00K 88.00K 17.60K
CEO Mr. Cameron Reynolds MBA Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Ari Bousbib Mr. Padraig McDonnell
Ratings
VNRX DHR-PB TMO DHR IQV A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
VNRX DHR-PB TMO DHR IQV A
Last Close $0.759 $1261.26 $607.14 $273.91 $239.67 $137.32
High 52 $1.37 $1261.26 $607.14 $273.91 $259.1 $154.64
Low 52 $0.57 $1261.26 $431.41 $185.1 $177.16 $101.17
Price vs. 52 Week High -44.6 % 0 % 0 % 0 % -7.5 % -11.2 %
Price vs. 52 Week Low 33.16 % 0 % 40.73 % 47.98 % 35.28 % 35.73 %
Total Return
VNRX DHR-PB TMO DHR IQV A
1 Month Return 20.29 % 0 % 10.23 % 8.8 % 12.65 % 4.98 %
3 Month Return -16.93 % 0 % 5.85 % 11.08 % 2.04 % -0.3 %
6 Month Return -29.07 % 0 % 10.93 % 17.56 % 10.91 % 4.83 %
9 Month Return -5.14 % 0 % 40.73 % 45.79 % 33.19 % 33.62 %
YTD Return 5.86 % 0 % 14.38 % 18.4 % 3.58 % -1.23 %
1 Year Return -40.7 % 0 % 8.41 % 7.3 % 6.73 % 8.42 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VNRX DHR-PB TMO DHR IQV A
Dividend Yield Percentage (TTM) - 0.38 % 0.24 % 0.38 % - 0.68 %
Dividend Paid and Capex Coverage Ration (TTM) -18.47 % 3.16 % 4.82 % 2.53 % 3.98 % 3.02 %
Dividend Per Share (TTM) - 1.05 % 1.48 % 1.05 % - 0.93 %
Payout Ratio (TTM) - 17.87 % 8.91 % 28.62 % - 21.74 %
Growth
VNRX DHR-PB TMO DHR IQV A
Asset Growth 52.78 % 0.16 % 1.62 % 0.16 % 5.3 % 2.35 %
Gross Profit Growth 27.86 % -25.94 % -21.93 % -25.94 % -17.76 % -6.9 %
Revenue Growth 153.04 % -24.09 % -4.58 % -24.09 % 4.13 % -0.22 %
Revenue 3 Year 3568.62 % 2.8 % 36.47 % 2.8 % 37.49 % 34.51 %
Revenue 5 Year - 14.24 % 83.24 % 14.24 % 59.72 % 51.82 %
Revenue 10 Year - 18.09 % 205.6 % 18.09 % 98.74 % 16.86 %
EBIT Growth -13.24 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Net Income Growth -16.68 % -33.92 % -13.74 % -33.92 % 24.47 % -1.12 %
Net Income 3 Yeari Growth Per Share -9.61 % 25.29 % -3.52 % 25.29 % 406.6 % 81.26 %
Net Income 5 Yeari Growth Per Share 13.58 % 70.95 % 112.51 % 70.95 % 481.09 % 328.44 %
Net Income 10 Yeari Growth Per Share -44.76 % 67.05 % 339.48 % 67.05 % 304.81 % 98.65 %
Operating Income Growth -13.24 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Operating Cash Flow Growth (CFG) -18.23 % -15.91 % -8.17 % -15.91 % -4.91 % 35.06 %
Operating 3 Year CFG 30.26 % 10.65 % 4.04 % 10.65 % 14.18 % 102.22 %
Operating 5 Year CFG 45.98 % 69.44 % 92.7 % 69.44 % 89.93 % 77.99 %
Operating 10 Year CFG 10.94 % 88.83 % 290.23 % 88.83 % 265.29 % 78.41 %
EPS Growth 9.09 % -34.29 % -12.41 % -34.29 % 26.98 % 0.72 %
EPS Diluted Growth 9.09 % -33.82 % -12.41 % -33.82 % 27.45 % 0.24 %
Book Value Per Share -135.44 % 5.14 % 7.9 % 5.14 % 8.21 % 12.39 %
Share Holder 3 Year Equity Growth Per Share -130.35 % 28.97 % 38.91 % 28.97 % 6.01 % 26.07 %
Share Holder 5 Year Equity Growth Per Share -128.32 % 80.33 % 76.4 % 80.33 % 0.89 % 39.74 %
Share Holder 10 Year Equity Growth Per Share -274.31 % 125.79 % 158.74 % 125.79 % 718.56 % 28.25 %
Dividend Per Share Growth - 50.21 % 16.73 % 50.21 % - 7.8 %
Dividend 3 Year Growth Per Share - 94.58 % 59.21 % 94.58 % - 25.46 %
Dividend 5 Year Growth Per Share - 173.92 % 104.77 % 173.92 % - 51.49 %
Dividend 10 Year Growth Per Share - 2163.67 % 125.8 % 2163.67 % - 97.03 %
Debt Growth 17.78 % -0.72 % 1.24 % -0.72 % 9.38 % -1.23 %
Free Cash Flow Growth -13.64 % -21.53 % 0.23 % -21.53 % -5.42 % 44.37 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023
Profitability
VNRX DHR-PB TMO DHR IQV A
Gross Profit Margin TTM -75.54 % 58.45 % 40.3 % 59.41 % 29.7 % 50.71 %
Return on Assets TTM -179.61 % 5.33 % 6.33 % 5.35 % 5.39 % 11.44 %
Return on Equity TTM 712.14 % 8.42 % 13.48 % 8.04 % 22.79 % 20.87 %
Return on Capital Employed TTM 292.99 % 7.39 % 8.76 % 6.21 % 10.68 % 14.65 %
Net Income Per EBT TTM 98.95 % 83.98 % 90.86 % 99.88 % 94.99 % 93.45 %
EBT Per Ebit TTM 99.86 % 94.74 % 93.52 % 94.37 % 70.93 % 101.92 %
EBIT Per Revenue TTM -4432.36 % 21.3 % 17.32 % 21.13 % 13.9 % 19.78 %
Cash Flow To Debt Ratio TTM -371.7 % 36.11 % 26.4 % 35.4 % 18.4 % 69.55 %
Receivables Turnover TTM 5.97 7.76 5.33 6.4 4.61 5.28
Payables Turnover TTM 0.4 6.49 - 5.21 3.23 7.05
Inventory Turnover TTM 1399123 4.12 4.86 3.21 - 3.25
Fixed Asset Turnover TTM 13.86 % 463.28 % 456.22 % 367.49 % 1979.04 % 429.94 %
Asset Turnover TTM 4.1 % 31.45 % 42.99 % 26.87 % 57.58 % 60.71 %
Operating Cash Flow Per Share TTM -0.22 9.27 24.47 8.74 13.39 6.47
Free Cash Flow Per Share TTM -0.23 7.39 20.85 6.92 10.03 5.25
Cash Per Share TTM 14.36 % 937.04 % 2309.69 % 321.85 % 920.97 % 570.31 %
Operating Cash Flow Sales Ratio TTM -2225.2 % 26.52 % 22.08 % 30.55 % 16.05 % 28.77 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.41 % 79.76 % 85.18 % 79.14 % 74.88 % 81.12 %
Cash Flow Coverage Ratios TTM -371.7 % 36.11 % 26.4 % 35.4 % 18.4 % 69.55 %
Price To Free Cash Flows Ratio TTM -3.37 35.66 29.1 38.77 23.91 26.05
Price To Operating Cash Flows Ratio TTM -3.51 29.55 24.81 31.34 17.9 21.22
Price Cash Flow Ratio TTM -3.51 29.55 24.81 31.34 17.9 21.22
Income Statement (TTM)
VNRX DHR-PB TMO DHR IQV A
Revenue $0B $23.89B $42.86B $23.89B $15.01B $6.83B
Gross Profit $-0B $14.03B $15.22B $14.03B $4.14B $3.47B
Gross Profit Ratio -82.07% 58.74% 35.52% 58.74% 27.56% 50.71%
EBITDA $-0.03B $7.76B $10.72B $7.76B $3.21B $1.71B
Net Income $-0.04B $4.76B $6B $4.76B $1.36B $1.24B
EPS Diluted -0.5 6.38 15.45 6.38 7.29 4.19
Balance Sheet (MRQ)
VNRX DHR-PB TMO DHR IQV A
Long Term Debt $0B $17.66B $31.31B $17.66B $12.96B $2.74B
Total Liabilities $0.04B $31B $51.88B $31B $20.57B $4.92B
Total Equity $-0.01B $53.49B $46.84B $53.49B $6.11B $5.85B
Total Investments $0B $0.01B $-1.92B $0.01B $0.36B $0.16B
Total Debt $0.01B $19.54B $34.92B $19.54B $14.23B $2.74B
Total Assets $0.03B $84.49B $98.73B $84.49B $26.68B $10.76B
Cash Flow Statement (TTM)
VNRX DHR-PB TMO DHR IQV A
Net Income $-0.04B $4.22B $6B $4.22B $1.36B $1.24B
Inventory $0B $0.19B $0.6B $0.19B $0B $-0.03B
Dividends Paid $0B $-1.25B $-0.52B $-1.25B $0B $-0.27B
Operating Cash Flow $-0.02B $7.16B $8.41B $7.16B $2.15B $1.77B
Capital Expenditure $-0B $-1.38B $-1.48B $-1.38B $-0.65B $-0.3B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 137.32
ACRS Aclaris Therapeutics, Inc. 1.39
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.4101
AWH Aspira Women's Health Inc. 1.49
BDSX Biodesix, Inc. 1.72
BIAF bioAffinity Technologies, Inc. 2.71
BIAFW bioAffinity Technologies, Inc. 0.55
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 0.627
BNR Burning Rock Biotech Limited 6.38
CDNA CareDx, Inc 19.01
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 2.01
CNTG Centogene N.V. 0.34
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 233.47
CSTL Castle Biosciences, Inc. 21.06
DGX Quest Diagnostics Incorporated 145.59
DHR Danaher Corporation 273.91
ETFs With Exposure to VNRX
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00003 119.77
VXF Vanguard Extended Market Index Fund 0 178.79
IWC iShares Micro-Cap ETF 0.00282 129.27
STSB iShares Factors US Small Blend Style ETF 0.01 47.635
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 135.6
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000464909 92.7
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 135.6
VEMPX Vanguard Extended Market Index InstlPlus 0 334.63
Unlock